Wijermans PW - Search Results

1

Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia.

Deenik W, van der Holt B, Verhoef GE, Smit WM, Kersten MJ, Kluin-Nelemans HC, Verdonck LF, Ferrant A, Schattenberg AV, Janssen JJ, Sonneveld P, van Marwijk Kooy M, Wittebol S, Willemze R, Wijermans PW, Westveer PH, Beverloo HB, Valk P, Löwenberg B, Ossenkoppele GJ, Cornelissen JJ. Deenik W, et al. Among authors: wijermans pw. Blood. 2008 Mar 1;111(5):2581-8. doi: 10.1182/blood-2007-08-107482. Epub 2008 Jan 2. Blood. 2008. PMID: 18172005 Free article. Clinical Trial.

2

Monocytic differentiation induction of HL-60 cells by MC 903, a novel vitamin D analogue.

Rebel VI, Ossenkoppele GJ, van de Loosdrecht AA, Wijermans PW, Beelen RH, Langenhuijsen MM. Rebel VI, et al. Among authors: wijermans pw. Leuk Res. 1992;16(5):443-51. doi: 10.1016/0145-2126(92)90169-8. Leuk Res. 1992. PMID: 1625469

3

Low-dose cytarabine for acute myeloid leukaemia and myelodysplastic syndromes: in vivo and in vitro cytotoxicity.

Ossenkoppele GJ, Wijermans PW, Nauta JJ, Huijgens PC, Langenhuijsen MM. Ossenkoppele GJ, et al. Among authors: wijermans pw. Eur J Cancer. 1991;27(7):842-5. doi: 10.1016/0277-5379(91)90130-6. Eur J Cancer. 1991. PMID: 1834114

4

Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignancies.

Huijgens PC, Ossenkoppele GJ, Weijers TF, van Loenen AC, Simoons-Smit AM, Wijermans PW, van Pampus EC, Langenhuijsen MM. Huijgens PC, et al. Among authors: wijermans pw. Eur J Haematol. 1991 Jan;46(1):42-6. doi: 10.1111/j.1600-0609.1991.tb00512.x. Eur J Haematol. 1991. PMID: 1988306 Clinical Trial.

5

Chemotherapy in non-Hodgkin's lymphoma during pregnancy.

Lambert J, Wijermans PW, Dekker GA, Ossenkoppele GJ. Lambert J, et al. Among authors: wijermans pw. Neth J Med. 1991 Feb;38(1-2):80-5. Neth J Med. 1991. PMID: 2030816

6

Maturation induction in freshly isolated human myeloid leukemic cells, 1.25 (OH)2 vitamin D3 being the most potent inducer.

Ossenkoppele GJ, Wijermans PW, Nauta JJ, Huijgens PC, Langenhuijsen MM. Ossenkoppele GJ, et al. Among authors: wijermans pw. Leuk Res. 1989;13(7):609-14. doi: 10.1016/0145-2126(89)90129-x. Leuk Res. 1989. PMID: 2548044

7

Low dose cytosine-arabinoside has only minimal differentiation inducing capacity in HL60 cells.

Ossenkoppele GJ, Wijermans PW, de Waal FC, vd Berg TA, Jalink W, Huijgens PC, Langenhuijsen MM. Ossenkoppele GJ, et al. Among authors: wijermans pw. Eur J Cancer Clin Oncol. 1989 Nov;25(11):1561-9. doi: 10.1016/0277-5379(89)90298-8. Eur J Cancer Clin Oncol. 1989. PMID: 2591448

8

Standard induction and low dose ara-C treatment in patients over 60 with AML or MDS.

van Geel BM, Huijgens PC, Ossenkoppele GJ, Wijermans PW, Langenhuijsen MM. van Geel BM, et al. Among authors: wijermans pw. Neth J Med. 1989 Oct;35(3-4):128-36. Neth J Med. 1989. PMID: 2601790

9

Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells: reversal of the bleeding disorder by cell differentiation.

Wijermans PW, Rebel VI, Ossenkoppele GJ, Huijgens PC, Langenhuijsen MM. Wijermans PW, et al. Blood. 1989 Feb 15;73(3):800-5. Blood. 1989. PMID: 2644991 Free article.

10

High-dose busulfan and amsacrine with autologous bone marrow rescue in patients with acute myeloid leukemia in first remission.

Huijgens PC, Ossenkoppele GJ, van der Weide M, Wijngaarden MJ, Reijneke RM, Wijermans PW, Langenhuijsen MM. Huijgens PC, et al. Among authors: wijermans pw. Cancer Treat Rep. 1987 May;71(5):552-3. Cancer Treat Rep. 1987. PMID: 3471331 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters